VERA Earnings

Quarterly EPS
$-0.85
Q3 2024
$-0.72
Q4 2024
$-0.81
Q1 2025
$-1.20
Q2 2025
$-1.26
Q3 2025
$-1.39
Q4 2025
$-1.69
Q1 2026
$-1.52
Q2 2026
Latest RevenueN/A
Latest Net Income-109720000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$1.520-109720000-26.7%
Q1 2026-$1.690-121974000-108.6%
Q4 2025-$1.390-91097000-93.1%
Q3 2025-$1.260-80293000-48.2%
Q2 2025-$1.200-76658000-93.5%
Q1 2025-$0.810-51433000-44.6%
Q4 2024-$0.720-43425000-24.1%
Q3 2024-$0.850-46632000-88.9%
Q2 2024-$0.620-33708000
Q1 2024-$0.560-28383000
Q4 2023-$0.580-25655000
Q3 2023-$0.450-20104000
Vera Therapeutics (VERA) — Earnings